This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Suzanne Osborn
Vice President & Chief Human Resources Officer
Contact
SuzanneOsborn@westat.comOverview
Suzanne Osborn is a Vice President and Chief Human Resources Officer (CHRO). She has 25+ years’ experience serving as a leader and strategic executive advisor in human resource issues. She is responsible for all human resource functions at Westat, including benefits, compensation, human resource information systems, employee relations, and recruitment. Her focus has been on creating continued efficiencies for business processes as well as driving the company culture that supports its values and contributes to being a compelling place to work.
Education
- MBA, Human Resources, Fairleigh Dickinson University
- BA, Psychology (with a minor in Mathematics), Ithaca College
-
Associations between biomarkers of nicotine/tobacco exposure and respiratory symptoms among adults who exclusively smoke cigarettes in the U.S.: Findings from the PATH Study Waves 1–4 (2013–2017)
17,
Addictive Behaviors Reports
January 2023
K.C. Edwards, J.E. Ozga, C. Reyes-Guzman, D. Smith, D. Hatsukami, J.L. Hart, A. Jackson, et al.
DOILink for: Associations between biomarkers of nicotine/tobacco exposure and respiratory symptoms among adults who exclusively smoke cigarettes in the U.S.: Findings from the PATH Study Waves 1–4 (2013–2017) -
Cycles of reform in the history of psychosis treatment in the United States
3,
SSM - Mental Health
January 2023
P. George, N. Jones, H. Goldman, Abram Rosenblatt
DOILink for: Cycles of reform in the history of psychosis treatment in the United States -
Estimation of COVID-19 mRNA vaccine effectiveness and COVID-19 illness and severity by vaccination status during Omicron BA.4 and BA.5 sublineage periods
6,
JAMA Network Open
January 2023
R. Link-Gelles, M.E. Levy, K. Natarajan, S.E. Reese, A.L. Naleway, S.J. Grannis, N.P. Klein, et al.
DOILink for: Estimation of COVID-19 mRNA vaccine effectiveness and COVID-19 illness and severity by vaccination status during Omicron BA.4 and BA.5 sublineage periods